ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.704,42
-0,11%
S&P 500
5.294,62
-0,05%
Dow Jones
39.916,06
0,12%
Euro vs US Dollar
1,08687
0,01%
Bitcoin
67.116,86
2,88%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Aquinox Pharmaceuticals Inc (AQXP)

  7. Aquinox Pharmaceuticals Inc (AQXP) News

AQXP

Aquinox Pharmaceuticals (AQXP)

Aquinox Pharmaceuticals Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:AQXP
DatumZeitQuelleÜberschriftSymbolFirma
13/11/201915h03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AQXPAquinox Pharmaceuticals Inc
13/11/201915h03Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AQXPAquinox Pharmaceuticals Inc
15/10/201923h20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AQXPAquinox Pharmaceuticals Inc
15/10/201922h49Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AQXPAquinox Pharmaceuticals Inc
15/10/201922h46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AQXPAquinox Pharmaceuticals Inc
15/10/201922h46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AQXPAquinox Pharmaceuticals Inc
15/10/201922h45Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AQXPAquinox Pharmaceuticals Inc
11/10/201914h35Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:AQXPAquinox Pharmaceuticals Inc
02/10/201922h16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AQXPAquinox Pharmaceuticals Inc
02/10/201914h39Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:AQXPAquinox Pharmaceuticals Inc
02/10/201914h36Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:AQXPAquinox Pharmaceuticals Inc
20/09/201914h31Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:AQXPAquinox Pharmaceuticals Inc
14/09/201901h19Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:AQXPAquinox Pharmaceuticals Inc
11/09/201923h39Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AQXPAquinox Pharmaceuticals Inc
04/09/201922h48Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AQXPAquinox Pharmaceuticals Inc
23/08/201921h59Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:AQXPAquinox Pharmaceuticals Inc
13/08/201923h08Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:AQXPAquinox Pharmaceuticals Inc
12/08/201923h55Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AQXPAquinox Pharmaceuticals Inc
12/08/201923h54Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:AQXPAquinox Pharmaceuticals Inc
12/08/201923h53Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:AQXPAquinox Pharmaceuticals Inc
12/08/201923h50Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:AQXPAquinox Pharmaceuticals Inc
12/08/201914h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AQXPAquinox Pharmaceuticals Inc
08/08/201923h02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AQXPAquinox Pharmaceuticals Inc
07/08/201923h29Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:AQXPAquinox Pharmaceuticals Inc
07/08/201914h00GlobeNewswire Inc.Neoleukin Therapeutics to Present at Canaccord Genuity 39th Annual Growth ConferenceNASDAQ:AQXPAquinox Pharmaceuticals Inc
06/08/201913h33Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AQXPAquinox Pharmaceuticals Inc
06/08/201913h00GlobeNewswire Inc.Aquinox Pharmaceuticals and Neoleukin Therapeutics announce merger agreementNASDAQ:AQXPAquinox Pharmaceuticals Inc
01/08/201915h02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AQXPAquinox Pharmaceuticals Inc
07/05/201915h02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AQXPAquinox Pharmaceuticals Inc
15/04/201922h34Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:AQXPAquinox Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:AQXP

Kürzlich von Ihnen besucht

LSE
BD24
Citi Fun 26
NASDAQ
MBINM
Merchants Bancorp
ASX
ASY
COIN
BTCHPGBP
DGFX
SLPUSDT
Small Love Potion
LSE
TIPG
Am Us Tips Gov
USOTC
HMDLF
HeraMED (PK)
FX
VNDGBP
VND vs Sterling
BIT
F19473
Vontobel Financial Produ...
COIN
MTRMETH
Materium
LSE
101V
LSE
IUSU
Is Sp500 Ut Ctr
NASDAQ
SGMA
Sigmatron
COIN
NCTTUSD
NameChangeToken
LSE
AM70
Cred Ag Co 27
COIN
MLNSUST
M-linus
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten